2,2-bis(bromomethyl)-1,3-propanediol and Chronic Disease

2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Das, AM; Illsinger, S; Keiser, M; Lentze, MJ; Lücke, T; Naim, HY	1

Other Studies

1 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Chronic Disease

Article	Year
Congenital and putatively acquired forms of sucrase-isomaltase deficiency in infancy: effects of sacrosidase therapy. Journal of pediatric gastroenterology and nutrition, 2009, Volume: 49, Issue:4 Topics: beta-Fructofuranosidase; Carbohydrate Metabolism, Inborn Errors; Chronic Disease; Diarrhea; Dietary Supplements; Female; Humans; Infant; Malabsorption Syndromes; Male; Sequence Analysis, DNA; Sucrase-Isomaltase Complex	2009

Article

Year

Congenital and putatively acquired forms of sucrase-isomaltase deficiency in infancy: effects of sacrosidase therapy.

Journal of pediatric gastroenterology and nutrition, 2009, Volume: 49, Issue:4

Topics: beta-Fructofuranosidase; Carbohydrate Metabolism, Inborn Errors; Chronic Disease; Diarrhea; Dietary Supplements; Female; Humans; Infant; Malabsorption Syndromes; Male; Sequence Analysis, DNA; Sucrase-Isomaltase Complex

2009